Evidence map›Paper›PMID 22342771›Full record

ReviewAdvanced drug delivery reviews2012

Strategies for controlled delivery of growth factors and cells for bone regeneration.

Tiffany N Vo, F Kurtis Kasper, Antonios G Mikos

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 241 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

241 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Future Frontiers in Bioinspired Implanted Biomaterials.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  19. Review
  20. Review

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tiffany N VoDepartment of Bioengineering, Rice University, Houston, TX 77251-1892, USA.
F Kurtis Kasper
Antonios G Mikos

Funding

Injectable Cellular Composites for Cartilage EngineeringR01AR048756 · NIAMS · RICE UNIVERSITY · PI KASPER, FRED KURTIS, MIKOS, ANTONIOS G. · 2003 to 2014
$3.3M
In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid ConstructsR01AR057083 · NIAMS · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2009 to 2013
$1.6M
NIAMS NIH HHS R01 AR048756NIAMS NIH HHS R01 AR057083NIAMS NIH HHS R01 AR48756NIAMS NIH HHS R01 AR57083NIDCR NIH HHS R01 DE017441NIDCR NIH HHS R01 DE17441
6 · The paper itself

Abstract

The controlled delivery of growth factors and cells within biomaterial carriers can enhance and accelerate functional bone formation. The carrier system can be designed with pre-programmed release kinetics to deliver bioactive molecules in a localized, spatiotemporal manner most similar to the natural wound healing process. The carrier can also act as an extracellular matrix-mimicking substrate for promoting osteoprogenitor cellular infiltration and proliferation for integrative tissue repair. This review discusses the role of various regenerative factors involved in bone healing and their appropriate combinations with different delivery systems for augmenting bone regeneration. The general requirements of protein, cell and gene therapy are described, with elaboration on how the selection of materials, configurations and processing affects growth factor and cell delivery and regenerative efficacy in both in vitro and in vivo applications for bone tissue engineering.

Indexed as

Bone RegenerationDrug Delivery SystemsAnimalsBiocompatible MaterialsBone and BonesDrug CarriersExtracellular MatrixHumansIntercellular Signaling Peptides and ProteinsTissue EngineeringTissue ScaffoldsBiocompatible MaterialsDrug CarriersIntercellular Signaling Peptides and Proteins

Identifiers

PMID22342771
PMCPMC3358582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.